To Compare the Efficacy and Safety of Oral SHR 7280 Tablets With Ganirelix Acetate Injection in Infertile Female Subjects
Status:
Recruiting
Trial end date:
2025-06-30
Target enrollment:
Participant gender:
Summary
This study is a multi-center, randomized, double-blind, positive drug-controlled,
non-inferiority Phase III clinical trial. The study will enroll approximately 316 infertile
female subjects undergoing controlled ovarian hyperstimulation (COH) for in vitro
fertilization (IVF) or intracytoplasmic sperm injection (ICSI) treatment.